Oncolytics Biotech
ONCY
#9112
Rank
HK$0.85 B
Marketcap
HK$7.90
Share price
-0.98%
Change (1 day)
66.77%
Change (1 year)

EPS for Oncolytics Biotech (ONCY)

EPS in 2025 (TTM): -HK$2.31

According to Oncolytics Biotech 's latest financial reports the company's current EPS (TTM) is -HK$2.32. In 2024 the company made an earnings per share (EPS) of -HK$2.24 an increase over its 2023 EPS that were of -HK$2.42.

EPS history for Oncolytics Biotech from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$2.313.25%
2024-HK$2.24-7.57%
2023-HK$2.42-2.45%
2022-HK$2.48-17.58%
2021-HK$3.01-12.46%
2020-HK$3.44-61.76%
2019-HK$8.9947.59%
2018-HK$6.09-14.18%
2017-HK$7.10-1.33%
2016-HK$7.1911.83%
2015-HK$6.43-52.2%
2014-HK$13.45-31.2%
2013-HK$19.55-45.51%
2012-HK$35.8819.76%
2011-HK$29.9625.91%
2010-HK$23.80-2.52%
2009-HK$24.41-4.93%
2008-HK$25.68-11.64%
2007-HK$29.06-235.81%
2006HK$21.400.38%
2005HK$21.32-8.29%
2004HK$23.2549.76%
2003HK$15.5273.66%
2002HK$8.94-10.07%
2001HK$9.94-191.05%
2000-HK$10.92111.79%
1999-HK$5.15

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Eli Lilly
LLY
HK$180.13-7,868.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.24-1,102.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-HK$95.62 4,024.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-HK$16.03 591.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$9.70-518.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-HK$6.57 183.50%๐Ÿ‡บ๐Ÿ‡ธ USA